nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—ADRA1D—polycystic ovary syndrome	0.236	0.368	CbGaD
Clonidine—ADRA1B—polycystic ovary syndrome	0.201	0.314	CbGaD
Clonidine—ADRA1A—polycystic ovary syndrome	0.135	0.211	CbGaD
Clonidine—SLC22A3—Metformin—polycystic ovary syndrome	0.132	0.66	CbGbCtD
Clonidine—CYP1A1—polycystic ovary syndrome	0.0691	0.108	CbGaD
Clonidine—SLC22A1—Metformin—polycystic ovary syndrome	0.0679	0.34	CbGbCtD
Clonidine—Viral diarrhoea—Metformin—polycystic ovary syndrome	0.00416	0.127	CcSEcCtD
Clonidine—Apraclonidine—ADRA1A—polycystic ovary syndrome	0.00166	0.853	CrCbGaD
Clonidine—CYP1A2—urine—polycystic ovary syndrome	0.00163	0.048	CbGeAlD
Clonidine—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00134	0.041	CcSEcCtD
Clonidine—CYP3A4—urine—polycystic ovary syndrome	0.00118	0.0348	CbGeAlD
Clonidine—CYP2D6—urine—polycystic ovary syndrome	0.00116	0.0342	CbGeAlD
Clonidine—NISCH—adrenal cortex—polycystic ovary syndrome	0.00109	0.0321	CbGeAlD
Clonidine—Ear pain—Metformin—polycystic ovary syndrome	0.000923	0.0283	CcSEcCtD
Clonidine—NISCH—uterus—polycystic ovary syndrome	0.000899	0.0264	CbGeAlD
Clonidine—NISCH—pituitary gland—polycystic ovary syndrome	0.000883	0.0259	CbGeAlD
Clonidine—NISCH—adipose tissue—polycystic ovary syndrome	0.000879	0.0258	CbGeAlD
Clonidine—Nasal congestion—Metformin—polycystic ovary syndrome	0.000864	0.0265	CcSEcCtD
Clonidine—Lethargy—Metformin—polycystic ovary syndrome	0.000803	0.0246	CcSEcCtD
Clonidine—SLC22A3—embryo—polycystic ovary syndrome	0.000802	0.0236	CbGeAlD
Clonidine—NISCH—adrenal gland—polycystic ovary syndrome	0.000788	0.0232	CbGeAlD
Clonidine—Pain in extremity—Metformin—polycystic ovary syndrome	0.000787	0.0241	CcSEcCtD
Clonidine—NISCH—female gonad—polycystic ovary syndrome	0.000735	0.0216	CbGeAlD
Clonidine—NISCH—vagina—polycystic ovary syndrome	0.000731	0.0215	CbGeAlD
Clonidine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000727	0.0223	CcSEcCtD
Clonidine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000719	0.022	CcSEcCtD
Clonidine—Breast disorder—Metformin—polycystic ovary syndrome	0.000711	0.0218	CcSEcCtD
Clonidine—Cramp muscle—Metformin—polycystic ovary syndrome	0.000709	0.0217	CcSEcCtD
Clonidine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000704	0.0216	CcSEcCtD
Clonidine—SLC22A4—endometrium—polycystic ovary syndrome	0.000645	0.019	CbGeAlD
Clonidine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000632	0.0194	CcSEcCtD
Clonidine—Drowsiness—Metformin—polycystic ovary syndrome	0.000607	0.0186	CcSEcCtD
Clonidine—SLC22A3—endometrium—polycystic ovary syndrome	0.000587	0.0172	CbGeAlD
Clonidine—SLC22A4—pituitary gland—polycystic ovary syndrome	0.000584	0.0172	CbGeAlD
Clonidine—SLC22A4—adipose tissue—polycystic ovary syndrome	0.000581	0.0171	CbGeAlD
Clonidine—ADRA1D—endocrine gland—polycystic ovary syndrome	0.000571	0.0168	CbGeAlD
Clonidine—Bradycardia—Metformin—polycystic ovary syndrome	0.000554	0.017	CcSEcCtD
Clonidine—SLC22A1—adipose tissue—polycystic ovary syndrome	0.000553	0.0163	CbGeAlD
Clonidine—Rhinitis—Metformin—polycystic ovary syndrome	0.000546	0.0167	CcSEcCtD
Clonidine—Hepatitis—Metformin—polycystic ovary syndrome	0.000545	0.0167	CcSEcCtD
Clonidine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000542	0.0166	CcSEcCtD
Clonidine—SLC22A3—adipose tissue—polycystic ovary syndrome	0.000529	0.0155	CbGeAlD
Clonidine—SLC22A4—adrenal gland—polycystic ovary syndrome	0.000521	0.0153	CbGeAlD
Clonidine—Eye disorder—Metformin—polycystic ovary syndrome	0.000509	0.0156	CcSEcCtD
Clonidine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000505	0.0155	CcSEcCtD
Clonidine—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.000499	0.0147	CbGeAlD
Clonidine—Angiopathy—Metformin—polycystic ovary syndrome	0.000494	0.0151	CcSEcCtD
Clonidine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000491	0.015	CcSEcCtD
Clonidine—SLC22A4—vagina—polycystic ovary syndrome	0.000483	0.0142	CbGeAlD
Clonidine—SLC22A5—adrenal cortex—polycystic ovary syndrome	0.000478	0.014	CbGeAlD
Clonidine—SLC22A3—adrenal gland—polycystic ovary syndrome	0.000474	0.0139	CbGeAlD
Clonidine—Erythema—Metformin—polycystic ovary syndrome	0.000474	0.0145	CcSEcCtD
Clonidine—SLC22A1—vagina—polycystic ovary syndrome	0.00046	0.0135	CbGeAlD
Clonidine—Muscle spasms—Metformin—polycystic ovary syndrome	0.000456	0.014	CcSEcCtD
Clonidine—Vision blurred—Metformin—polycystic ovary syndrome	0.000447	0.0137	CcSEcCtD
Clonidine—ADRA2C—endometrium—polycystic ovary syndrome	0.000445	0.0131	CbGeAlD
Clonidine—Tremor—Metformin—polycystic ovary syndrome	0.000444	0.0136	CcSEcCtD
Clonidine—SLC22A3—female gonad—polycystic ovary syndrome	0.000442	0.013	CbGeAlD
Clonidine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00044	0.0135	CcSEcCtD
Clonidine—SLC22A3—vagina—polycystic ovary syndrome	0.00044	0.0129	CbGeAlD
Clonidine—SLC22A1—endocrine gland—polycystic ovary syndrome	0.00043	0.0127	CbGeAlD
Clonidine—Malaise—Metformin—polycystic ovary syndrome	0.000428	0.0131	CcSEcCtD
Clonidine—SLC22A5—endometrium—polycystic ovary syndrome	0.000427	0.0125	CbGeAlD
Clonidine—Syncope—Metformin—polycystic ovary syndrome	0.000425	0.013	CcSEcCtD
Clonidine—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000421	0.0124	CbGeAlD
Clonidine—Palpitations—Metformin—polycystic ovary syndrome	0.000419	0.0128	CcSEcCtD
Clonidine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000417	0.0128	CcSEcCtD
Clonidine—SLC22A3—endocrine gland—polycystic ovary syndrome	0.000411	0.0121	CbGeAlD
Clonidine—ADRA2C—uterus—polycystic ovary syndrome	0.000411	0.0121	CbGeAlD
Clonidine—SLC6A2—adrenal gland—polycystic ovary syndrome	0.000407	0.0119	CbGeAlD
Clonidine—Chest pain—Metformin—polycystic ovary syndrome	0.000404	0.0124	CcSEcCtD
Clonidine—ADRA2C—pituitary gland—polycystic ovary syndrome	0.000403	0.0118	CbGeAlD
Clonidine—ADRA2C—adipose tissue—polycystic ovary syndrome	0.000401	0.0118	CbGeAlD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000401	0.0123	CcSEcCtD
Clonidine—Discomfort—Metformin—polycystic ovary syndrome	0.000399	0.0122	CcSEcCtD
Clonidine—Oedema—Metformin—polycystic ovary syndrome	0.000387	0.0118	CcSEcCtD
Clonidine—SLC22A5—pituitary gland—polycystic ovary syndrome	0.000386	0.0113	CbGeAlD
Clonidine—SLC22A5—adipose tissue—polycystic ovary syndrome	0.000385	0.0113	CbGeAlD
Clonidine—Infection—Metformin—polycystic ovary syndrome	0.000384	0.0118	CcSEcCtD
Clonidine—Shock—Metformin—polycystic ovary syndrome	0.000381	0.0117	CcSEcCtD
Clonidine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000379	0.0116	CcSEcCtD
Clonidine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000379	0.0116	CcSEcCtD
Clonidine—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000378	0.0111	CbGeAlD
Clonidine—Skin disorder—Metformin—polycystic ovary syndrome	0.000376	0.0115	CcSEcCtD
Clonidine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000374	0.0115	CcSEcCtD
Clonidine—Anorexia—Metformin—polycystic ovary syndrome	0.000369	0.0113	CcSEcCtD
Clonidine—Hypotension—Metformin—polycystic ovary syndrome	0.000362	0.0111	CcSEcCtD
Clonidine—ADRA2C—adrenal gland—polycystic ovary syndrome	0.00036	0.0106	CbGeAlD
Clonidine—ADRA2A—endometrium—polycystic ovary syndrome	0.000355	0.0104	CbGeAlD
Clonidine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000353	0.0108	CcSEcCtD
Clonidine—SLC6A2—endocrine gland—polycystic ovary syndrome	0.000353	0.0104	CbGeAlD
Clonidine—CYP1A1—uterus—polycystic ovary syndrome	0.000351	0.0103	CbGeAlD
Clonidine—Paraesthesia—Metformin—polycystic ovary syndrome	0.000347	0.0106	CcSEcCtD
Clonidine—Dyspnoea—Metformin—polycystic ovary syndrome	0.000345	0.0106	CcSEcCtD
Clonidine—SLC22A5—adrenal gland—polycystic ovary syndrome	0.000345	0.0101	CbGeAlD
Clonidine—Somnolence—Metformin—polycystic ovary syndrome	0.000344	0.0105	CcSEcCtD
Clonidine—CYP1A1—adipose tissue—polycystic ovary syndrome	0.000344	0.0101	CbGeAlD
Clonidine—Decreased appetite—Metformin—polycystic ovary syndrome	0.000336	0.0103	CcSEcCtD
Clonidine—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000336	0.00988	CbGeAlD
Clonidine—ADRA2C—female gonad—polycystic ovary syndrome	0.000336	0.00987	CbGeAlD
Clonidine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000334	0.0102	CcSEcCtD
Clonidine—ADRA2C—vagina—polycystic ovary syndrome	0.000334	0.00981	CbGeAlD
Clonidine—Fatigue—Metformin—polycystic ovary syndrome	0.000334	0.0102	CcSEcCtD
Clonidine—Constipation—Metformin—polycystic ovary syndrome	0.000331	0.0101	CcSEcCtD
Clonidine—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000328	0.00963	CbGeAlD
Clonidine—ADRA2A—uterus—polycystic ovary syndrome	0.000328	0.00963	CbGeAlD
Clonidine—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000322	0.00945	CbGeAlD
Clonidine—SLC22A5—female gonad—polycystic ovary syndrome	0.000322	0.00945	CbGeAlD
Clonidine—ADRA2A—adipose tissue—polycystic ovary syndrome	0.00032	0.00942	CbGeAlD
Clonidine—SLC22A5—vagina—polycystic ovary syndrome	0.00032	0.0094	CbGeAlD
Clonidine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000319	0.00976	CcSEcCtD
Clonidine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000316	0.00969	CcSEcCtD
Clonidine—Urticaria—Metformin—polycystic ovary syndrome	0.000307	0.00941	CcSEcCtD
Clonidine—Abdominal pain—Metformin—polycystic ovary syndrome	0.000306	0.00937	CcSEcCtD
Clonidine—CYP1A1—female gonad—polycystic ovary syndrome	0.000287	0.00845	CbGeAlD
Clonidine—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000287	0.00845	CbGeAlD
Clonidine—Diclofenac—CYP1A1—polycystic ovary syndrome	0.000286	0.147	CrCbGaD
Clonidine—CYP1A1—vagina—polycystic ovary syndrome	0.000286	0.0084	CbGeAlD
Clonidine—CYP3A5—female gonad—polycystic ovary syndrome	0.000281	0.00826	CbGeAlD
Clonidine—CYP3A5—vagina—polycystic ovary syndrome	0.000279	0.00821	CbGeAlD
Clonidine—Asthenia—Metformin—polycystic ovary syndrome	0.000278	0.0085	CcSEcCtD
Clonidine—Pruritus—Metformin—polycystic ovary syndrome	0.000274	0.00838	CcSEcCtD
Clonidine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000271	0.00797	CbGeAlD
Clonidine—ABCB1—embryo—polycystic ovary syndrome	0.000271	0.00796	CbGeAlD
Clonidine—ADRA2A—female gonad—polycystic ovary syndrome	0.000268	0.00788	CbGeAlD
Clonidine—CYP1A1—endocrine gland—polycystic ovary syndrome	0.000267	0.00786	CbGeAlD
Clonidine—ADRA2A—vagina—polycystic ovary syndrome	0.000266	0.00783	CbGeAlD
Clonidine—Diarrhoea—Metformin—polycystic ovary syndrome	0.000265	0.00811	CcSEcCtD
Clonidine—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000261	0.00768	CbGeAlD
Clonidine—Dizziness—Metformin—polycystic ovary syndrome	0.000256	0.00783	CcSEcCtD
Clonidine—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000249	0.00732	CbGeAlD
Clonidine—Vomiting—Metformin—polycystic ovary syndrome	0.000246	0.00753	CcSEcCtD
Clonidine—Rash—Metformin—polycystic ovary syndrome	0.000244	0.00747	CcSEcCtD
Clonidine—Dermatitis—Metformin—polycystic ovary syndrome	0.000244	0.00746	CcSEcCtD
Clonidine—Headache—Metformin—polycystic ovary syndrome	0.000242	0.00742	CcSEcCtD
Clonidine—Nausea—Metformin—polycystic ovary syndrome	0.00023	0.00704	CcSEcCtD
Clonidine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000222	0.00652	CbGeAlD
Clonidine—CYP2D6—female gonad—polycystic ovary syndrome	0.000208	0.0061	CbGeAlD
Clonidine—ABCB1—endometrium—polycystic ovary syndrome	0.000198	0.00582	CbGeAlD
Clonidine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000196	0.00577	CbGeAlD
Clonidine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000193	0.00567	CbGeAlD
Clonidine—ABCB1—uterus—polycystic ovary syndrome	0.000183	0.00536	CbGeAlD
Clonidine—ABCB1—pituitary gland—polycystic ovary syndrome	0.000179	0.00527	CbGeAlD
Clonidine—ABCB1—adipose tissue—polycystic ovary syndrome	0.000179	0.00525	CbGeAlD
Clonidine—ABCB1—adrenal gland—polycystic ovary syndrome	0.00016	0.00471	CbGeAlD
Clonidine—ABCB1—female gonad—polycystic ovary syndrome	0.000149	0.00439	CbGeAlD
Clonidine—ABCB1—vagina—polycystic ovary syndrome	0.000148	0.00436	CbGeAlD
Clonidine—ABCB1—endocrine gland—polycystic ovary syndrome	0.000139	0.00408	CbGeAlD
Clonidine—ADRA2A—Metabolism—TH—polycystic ovary syndrome	6.26e-06	6.98e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	6.25e-06	6.97e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—GNAS—polycystic ovary syndrome	6.24e-06	6.96e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	6.22e-06	6.94e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.17e-06	6.88e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	6.14e-06	6.85e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	6.13e-06	6.83e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	6.1e-06	6.81e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	6.09e-06	6.79e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	6.07e-06	6.77e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.07e-06	6.77e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	6.05e-06	6.75e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NGFR—polycystic ovary syndrome	6.03e-06	6.73e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.03e-06	6.73e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	6.03e-06	6.72e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—POMC—polycystic ovary syndrome	6e-06	6.69e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—NCOR1—polycystic ovary syndrome	5.99e-06	6.68e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	5.99e-06	6.68e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	5.99e-06	6.68e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	5.99e-06	6.68e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PRL—polycystic ovary syndrome	5.98e-06	6.67e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.94e-06	6.63e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	5.94e-06	6.62e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	5.9e-06	6.58e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	5.88e-06	6.56e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	5.88e-06	6.56e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NRG1—polycystic ovary syndrome	5.83e-06	6.5e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	5.81e-06	6.48e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	5.77e-06	6.44e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.76e-06	6.43e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	5.74e-06	6.4e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—TH—polycystic ovary syndrome	5.74e-06	6.4e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	5.72e-06	6.38e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	5.72e-06	6.38e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.72e-06	6.38e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	5.72e-06	6.37e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—CYP1A1—polycystic ovary syndrome	5.68e-06	6.34e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.67e-06	6.33e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.67e-06	6.33e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	5.67e-06	6.32e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—GNAS—polycystic ovary syndrome	5.63e-06	6.28e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.58e-06	6.23e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	5.58e-06	6.22e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.57e-06	6.22e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	5.57e-06	6.21e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	5.57e-06	6.21e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	5.57e-06	6.21e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.55e-06	6.19e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	5.54e-06	6.18e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.54e-06	6.18e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	5.45e-06	6.08e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	5.44e-06	6.07e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	5.44e-06	6.07e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—TH—polycystic ovary syndrome	5.42e-06	6.04e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	5.38e-06	6e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.36e-06	5.98e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	5.36e-06	5.98e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	5.34e-06	5.96e-05	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	5.33e-06	5.95e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	5.31e-06	5.92e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—MTHFR—polycystic ovary syndrome	5.3e-06	5.91e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	5.27e-06	5.88e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	5.27e-06	5.88e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	5.27e-06	5.88e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NRG1—polycystic ovary syndrome	5.27e-06	5.87e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—GNAS—polycystic ovary syndrome	5.26e-06	5.87e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	5.25e-06	5.85e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	5.24e-06	5.85e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	5.23e-06	5.83e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.18e-06	5.78e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	5.18e-06	5.77e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.15e-06	5.75e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	5.13e-06	5.73e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	5.11e-06	5.7e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	5.08e-06	5.67e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	5.07e-06	5.66e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	5.07e-06	5.65e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.04e-06	5.62e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.01e-06	5.59e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	5e-06	5.58e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IRS2—polycystic ovary syndrome	5e-06	5.57e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.96e-06	5.53e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	4.96e-06	5.53e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.94e-06	5.51e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.93e-06	5.5e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NRG1—polycystic ovary syndrome	4.92e-06	5.49e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	4.9e-06	5.47e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—LEP—polycystic ovary syndrome	4.89e-06	5.45e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	4.87e-06	5.43e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	4.87e-06	5.43e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	4.86e-06	5.42e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	4.85e-06	5.41e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	4.84e-06	5.4e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	4.79e-06	5.34e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	4.71e-06	5.26e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.71e-06	5.25e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	4.7e-06	5.24e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	4.68e-06	5.22e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.68e-06	5.22e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	4.61e-06	5.15e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.61e-06	5.14e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.6e-06	5.13e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	4.53e-06	5.05e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.51e-06	5.03e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	4.46e-06	4.97e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	4.42e-06	4.93e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	4.41e-06	4.92e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.38e-06	4.89e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	4.36e-06	4.86e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	4.35e-06	4.85e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—TH—polycystic ovary syndrome	4.33e-06	4.83e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.32e-06	4.82e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	4.3e-06	4.8e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.3e-06	4.8e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.3e-06	4.79e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	4.3e-06	4.79e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	4.29e-06	4.79e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.27e-06	4.76e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.26e-06	4.76e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	4.24e-06	4.72e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	4.23e-06	4.72e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	4.21e-06	4.7e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	4.21e-06	4.7e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—INS—polycystic ovary syndrome	4.21e-06	4.7e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	4.21e-06	4.7e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	4.2e-06	4.68e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.2e-06	4.68e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	4.18e-06	4.66e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.15e-06	4.62e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	4.12e-06	4.6e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	4.12e-06	4.59e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	4.08e-06	4.55e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.07e-06	4.54e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.07e-06	4.54e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	4.06e-06	4.53e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	4.06e-06	4.53e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	4.06e-06	4.52e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	4.04e-06	4.51e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	4.04e-06	4.5e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—INS—polycystic ovary syndrome	4.04e-06	4.5e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	3.99e-06	4.46e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.99e-06	4.45e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	3.97e-06	4.42e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	3.96e-06	4.41e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	3.94e-06	4.4e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	3.94e-06	4.39e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.84e-06	4.28e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	3.79e-06	4.23e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	3.77e-06	4.21e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.74e-06	4.17e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	3.73e-06	4.16e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	3.72e-06	4.15e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.68e-06	4.11e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	3.68e-06	4.1e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.65e-06	4.07e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.64e-06	4.06e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.62e-06	4.04e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	3.62e-06	4.04e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	3.6e-06	4.02e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	3.54e-06	3.95e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	3.53e-06	3.94e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	3.52e-06	3.93e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.49e-06	3.9e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	3.49e-06	3.89e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	3.49e-06	3.89e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	3.47e-06	3.87e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.46e-06	3.86e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	3.46e-06	3.85e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	3.44e-06	3.84e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.42e-06	3.82e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—INS—polycystic ovary syndrome	3.42e-06	3.82e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	3.41e-06	3.8e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	3.4e-06	3.8e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	3.37e-06	3.75e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	3.36e-06	3.75e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.36e-06	3.74e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.35e-06	3.74e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.35e-06	3.74e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	3.35e-06	3.73e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	3.33e-06	3.71e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.31e-06	3.7e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.24e-06	3.61e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.22e-06	3.59e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	3.2e-06	3.57e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	3.19e-06	3.56e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.18e-06	3.55e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	3.17e-06	3.54e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	3.16e-06	3.52e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	3.15e-06	3.52e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—INS—polycystic ovary syndrome	3.14e-06	3.5e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.13e-06	3.49e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	3.1e-06	3.45e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	3.09e-06	3.45e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.08e-06	3.44e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	3.08e-06	3.43e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	3.02e-06	3.37e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	3.01e-06	3.35e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.99e-06	3.33e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	2.98e-06	3.32e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.98e-06	3.32e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.98e-06	3.32e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	2.97e-06	3.32e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—INS—polycystic ovary syndrome	2.96e-06	3.3e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	2.88e-06	3.21e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	2.86e-06	3.19e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.83e-06	3.15e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	2.82e-06	3.15e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.8e-06	3.13e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.79e-06	3.11e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.77e-06	3.09e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.77e-06	3.08e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	2.69e-06	3e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.67e-06	2.97e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.64e-06	2.94e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.63e-06	2.93e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.61e-06	2.91e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.59e-06	2.89e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.56e-06	2.86e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.55e-06	2.84e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.44e-06	2.72e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	2.41e-06	2.69e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.38e-06	2.66e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	2.38e-06	2.65e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.37e-06	2.65e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—INS—polycystic ovary syndrome	2.37e-06	2.64e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.28e-06	2.54e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2.27e-06	2.53e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	2.24e-06	2.5e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	2.23e-06	2.49e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.23e-06	2.48e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.19e-06	2.44e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.18e-06	2.43e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.12e-06	2.36e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.07e-06	2.31e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.97e-06	2.19e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.95e-06	2.17e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.93e-06	2.15e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.9e-06	2.12e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.89e-06	2.11e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.83e-06	2.04e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	1.82e-06	2.04e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.81e-06	2.02e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	1.65e-06	1.84e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.54e-06	1.72e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.51e-06	1.69e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.49e-06	1.66e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.47e-06	1.63e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.46e-06	1.63e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.35e-06	1.5e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.25e-06	1.39e-05	CbGpPWpGaD
